ArticleDisease models & mechanisms2025
Impaired cortical development and translational control in a missense mouse model of DDX3X syndrome.
Article in Disease models & mechanisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- From chromatin to proteostasis: multilevel gene regulation in Mendelian diseases.Frontiers in epigenetics and epigenomics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Heterozygous mutations in the X-linked RNA helicase DDX3X cause DDX3X syndrome, a rare neurodevelopmental disorder associated with cortical malformations and autism spectrum disorder. Among ∼200 known DDX3X variants, half are missense, while the remainder are predicted loss-of-function (LoF) variants. LoF mouse models reveal that Ddx3x controls progenitors' ability to generate excitatory neurons. Yet, how missense mutations impact corticogenesis in vivo is unknown. Here, we generated a conditional mouse model of DDX3XT532M, a clinically severe and recurrent DDX3X syndrome variant found in affected females. Using Emx1-Cre-mediated expression of Ddx3xT532M in cortical progenitors, we showed that Ddx3xT532M alters corticogenesis. Ddx3xT532M conditional hemizygous males have severe microcephaly and apoptosis. In contrast, Ddx3xT532M conditional heterozygous (cHet) females exhibit mild reductions in cortical size and neurogenesis. Using polysome fractionation of Ddx3xT532M and Ddx3xLoF cHet female cortices, we discovered that Ddx3xT532M affects translation, with Ddx3xT532M cHet females showing qualitative differences from Ddx3xLoF cHet females. Collectively, these findings suggest that although Ddx3xT532M and Ddx3xLoF have similar impacts on corticogenesis in cHet females, they have distinct molecular targets. Our study establishes a new in vivo model for understanding the etiology of DDX3X syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.